EGHTESAD B, Aucejo F, Fung JJ. Preservation solutions in liver transplantation: What are the options? [editorial]. Liver Transpl. 2006;12:196–198
MANGUS et al.: Comparison of Histidine-Tryptophan-Ketoglutarate Solution and University of Wisconsin Solution for Organ Preservation in Liver Transplantation. Liver Transplantation 12:226-230, 2006
AGARWAL et al.: Comparison of Histidine-Tryptophan-Ketoglutarate Solution and University of Wisconsin Solution in Prolonged Cold Preservation of Kidney Allografts Transplantation 2006 Feb 15;81:480-2
RINGE et al.: Safety and efficacy of living donor liver preservation with HTK solution. Transplant Proc. 2005;37:316–319
AGARWAL et al. Follow-up Experience Using Histidine-Tryptophan-Ketoglutarate Solution in Clinical Pancreas Transplantation Transplantation Proceedings, 37, 3523–3526, 2005
AGARWAL et al.Comparison of Histidine-Tryptophan-Ketoglutarate and University of Wisconsin Solutions as Primary Preservation in Renal Allografts Undergoing Pulsatile Perfusion” Transplantation Proceedings, 37, 2005
POTDAR, S. et al: Initial experience using histidine-tryptophan-ketoglutarate solution in clinical pancreas transplantation. Clin Transplantation 18 (2004), 661-665
WILSON, CR Et al: Evaluation of eight preservation solutions for endothelial in situ preservation. Transplantation 78 (2004), 1008-1013
POKORNY H, et al.: Histidine-tryptophan-ketoglutarate solution for organ preservation in human liver transplantation — a prospective multi-centre observation study. Transpi mt 17 (2004), 256-260
FRI DELL, JA. et al.: Comparison of histidine-tryptophan-ketoglutarate solution and university of Wisconsin Solution for organ preservation in clinical pancreas transplantation. Transplantation 77 (2004), 1304-1306
CANELO, R. et al.: Experience with Histidine-Tryptophan-Ketoglutarate vs. University Wisconsin Preservation Solutions in Transplantation. Int. Surg 88: (2003), 145-151
TESTA, G. et al.: Histidine-Tryptophan-Ketoglutarate Versus University of Wisconsin Solution in Living Donor Liver Transplantation: Results of a Prospective Study. Liver Transplantation 9: (2003), 822-826
TROISI, R. et al.: Functional and structural integrity of porcine pancreatic grafts subjected to a period of warm ischemia and cold preservation with histidine-tryptophan-ketoglutarate (Custodiol) or University of Wisconsin solution. Transplantation 75 (2003), 1793-1799
TROISI, R. et al.: Physiologic and metabolic results of pancreatic cold storage with Histidine-Tryptophan-Ketog lutarate-HTK solution (Custod io l©) in the porcine autotranspiantation model. Transpi. Int. 13: (2000), 98-105
BOER, J. de et al.: Eurotransplant randomized multicenter kidney graft preservation study comparing HTK with UW and Euro-Collins. Transpl. lnt. 12 (1999), 447-453
HESSE, U.J. et al.: Organ preservation with HTK and UW solution. Pabst Sci. Publishers, D-49525 Lengerich, 1999
HESSE, U.J. et al.: Cold preservation of the porcine pancreas with histidine-tryptophan-ketoglutarate solution. Transplantation 66 (1998), 1137- 1141
HELLINGER, A. et al.: Preservation of pig liver allografts after warm ischemia: norrnothermic perfusion versus cold storage. Langenbecks Arch. Chir. 382 (1997), 175-184
HATANO, E. et al: Hepatic preservation with histidine-tryptophan-ketoglutarate solution in living related and cadaveric liver transplantation. Clinical Science 93 (1997), 81-88
PLAS, E. et al.: Experience in renal autotranspiantation: analysis of a clinical series. Br Journal of Urology, 77 (1996), 518-523
HATANO, E. et al.: Superiority of HTK Solution to UW Solution for Tissue Oxygenation in Living Related Liver Transplantation. Transpi. Proceedings 28 (1996), 1880-1881
LUDWIG, A. et al.: Effects of various HTK solution regiments on proteinuria after renal transplantation in dogs. Urol. Res. 23 (1995), 351-360
ERHARD, J. et al.: Untersuchungen zur Konservierung der Leber. Pabst- Verlag, 1995
PETRICONI, R.Ch.G. et al.: Kontinuierliche in-situ-Kaltperfusion mit HTKLosung bel konservativer Nierentumorchirurgie. Urologe [A] 34 (1995), 449- 456
PETRITSCH, P.H. et al.: Indikation und Ergebnisse der Ex-vivo-Chirurgie der Mere. Wien. kIln. Wschr. 107 (1995), 731-735
PETRICONI, R.Ch.G. et al.: Nouvelle technique de rénoprotection hypotherrnique dans Ia chirurgie tumorale sur rein unique. Journal d’Urologie, 101 (1995), 125-131
GROENEWOUD, A.F. et al.: A final report of the Eurotransplant randomised multicenter study comparing kidney graft preservation with HTK, UW and EC solution. 7th Congress of Europ. Soc. for Organ Transplantation, ESOT ‘95, Vienna
GSCHWEND, J.E. et al.: Continuous in situ cold perfusion with histidine tryptophan ketoglutarate solution in nephron sparing surgery for renal tumors. J. of Urology, 154 (1995), 1307-1311
KALLERHOFF, M. et al.: Kidney Preservation In Situ and Conservative Treatment of Renal Cell Carcinoma: Application of HTK Solution (Custodiol). Investigative Urology V, Chapmann + Hall (1994)
HAUSMANN, W. et al: Organerhaltende Nierentumorchirurgie bei Einzelniere mit Doppelnierenarterie unter lschamieprotektion. Akt. Urol. 26 (1995), 59-62
GUBERNATIS, G. et al.: Spenderorgankriterien und Konservierung — die QualitätderSpenderleber. Chirurgische Gastroenterologie, 10 (1994), 417- 421
ERHARD, J. et al.: Comparison of histidine-tryptophan-ketoglutarate (HTK) solution versus University of Wisconsin (UW) solution for organ preservation in human liver transplantation. Transpi. mt. 7(1994), 177-181
GUBERNATIS, G.: Uniform Standardized Technique of Donor Liver Removal Irrespective of Arterial Anomalies. Transplantation Proceedings 25 (1993), 3160-3161
KALLERHOFF, M. et al: Organerhaltende Nierentumorchirurgie in situ unter lschamieprotektion. Akt. Urol. 24 (1993), 1-VIll
LEON HARDT, U. et al.: The Effect of Different Solutions for Organ Preservation on Immediate Postischemic Pancreatic Function in Vitro. Transplantation, 55(1993), 11-14
BLECH, M. et aL: Nierenprotektion mit der HTK Losung. In: Beiträge zur Transplantationsmedizin (A.E. Lison Hrsg.), W. Pabst Verlag, Band 12 (1992)
HAUSS, J. et al.: La Chirurgie du foie ex vivo, in et ex situ, sous protection d’une perfusion hypothermique hepatique. Lyon Chir. 87 (1991), 437-441
WALCHER, F. et al.: The impact of liver preservation in HTK and UW solution on microcirculation after liver transplantation. Transplant mt. 5 (Suppl.1) (1992), 340-342
GROENEWOUD, A.F. et al.: A preliminary report of the HTK randomized multicenter study comparing kidney graft preservation with HTK and EuroCollins solutions. Transplant mt. 5 (Suppl.1) (1992), 429-432
ISEMER, F.-E. et al.: Clearanceverhalten der Niere gegenuberANF im autologen Hundetransplantationsmodell. Langenbecks Arch. Chir. 376 (1991), 363-366
HOLSCHER, M. et al.: Current Status of the HTK Solution of Bretschneider in Organ Preservation. Transplantation Proceedings, Vol. 23, No 5 (October) (1991), 2334-2337
AMINALAI, A. et al.: Morphological investigation of the porcine liver directly following preservation with Euro-Collins, University of Wisconsin and Bretschneider’s HTK solution. Langenbecks Arch. Chir. 376 (1992)
KALLERHOFF, M. et al.: A new method for renal perfusion fixation. S. 238-245
KALLERHOFF, M. et al.: Ergebnisse der Nierenfunktion nach Transplantation bei Protektion mit der Eurocollins-, der UW- oder der HTKLosung. Akt. Urol. 22 (1991), 310-314
ERHARD, J. et al.: Transplantation of the liver after preservation with the cardioplegic solution of Bretschneider. Lancet 2 (1990)
NIEBEL, W. et al.: Uberbruckung einer subtotalen Ureternekrose nach Verbrennungstrauma mittels Autotransplantation der Niere und PyeloCystostomie. Der Chirurg 60 (1989), 707-710
GUBERNATIS, G. et al.: Extended Cold Preservation Time (20 Hours 20 Minutes) of a Human Liver Graft by Using Cardioplegic HTK Solution. Transplantation Proceedings, Vol.23, No. 5 (1991)
HOLSCHER, M. lschämietoleranz bei In-situ-Operationen und Transpiantationen von Nieren. Fortschr. Med. 102 (1984), 1138-1140
KEHRER, G. et al. Gunstige Effekte einer Glucose-Prämedikation auf den aeroben Energieumsatz cler Hundenieren bei Protektion mit einer histidingepufferten Losung im Vergleich zu einer OsmofundinPrãmedikation. in: Experimentelle Urologie (Hrsg.) v.R. Harzmann et a!., Springer, Berlin, 1985, 172-179
KEHRER, G. et al.: Construction and Experimental Application of a Catheter for Selective Arterial Kidney Perfusion in situ. Urol. Res. 13 (1985), 85-89
KALLERHOFF, M. et al.: Expenmentelle Anwendung der kardioplegischen Losung HTK nach Bretschneider für eine in-situ-Protektion von Nieren. in: Experimentelle Urologie (Hrsg.) v. R. Harzmann et aL, Springer, Berlin, 1985, 180-188
Kallerhoff, M. et al.: Effects of preservation conditions and temperature on tissue acidification in canine kidneys. Transplantation 39 (1985), 485-489
KALLERHOFF, M. et al.: Post- lschemic Renal Function After Kidney Protection with the HTK Solution of Bretschneider. Urol. Res. 14 (1986), 271-277
KALLERHOFF, M. et al.: Short-Term Perfusion and “Equilibration” of Canine Kidneys with Protective Solutions. Urol. Res. 15 (1987), 5-12
KALLERHOFF, M. et al.: Nierenfunktionsparameter nach !schämiebelastung unter der Euro-Colliins-Losung oder unter der kardioplegischen Losung HTK nach Bretschneider. Urologe (A) 26 (1987), 96-103
PICHLMAYR, R. et al.: Ex situ Operation an der Leber. Eine neue Moglichkeit in der Leberchirurgie. Langenbecks Arch. f. Chir. 373 (1988), 122-126
KALLERHOFF, M. et al.:Verbesserung der lschämietoleranz des Pankreas. Niedersachs. Arzteblatt 11(1988)
KALLERHOFF, M. et al.:Metabolic, Energetic and Structural Changes in Protected and Unprotected Kidneys at Temperatures of bC and 25oC. Urol. Res. 16 (1988), 57-62
BRETSCHNEIDER, h.J. et al.:Nierenprotektion. KIm. Wochenschr. 66 (1988), 817-827
BLECH, M. et al.:Klinische Anwendung der kardioplegischen Losung HTK nach Bretschneider zur in-situ-Protektion der Niere. Urologe (A) 27 (1988), 44-48
ISEMER, F.E. et al.: Kidney Procurement with the HTK Solution of Bretschneider. Transplantation Proceedings, Vol. XX, No.5 (Oct.) 1988, p. 855-866
KEHRER, G. et al. Postischemic interrelations between energy metabolism and functional recovery of protected canine kidneys. Europ. J. Clin. Invest. 19 (1989) 328-336
KEHRER, G. et al.: Urinary LDH release for evaluation of postischemic renal function. Kim. Wschr. 67 (1989), 477-485
KALLERHOFF, M.: Nierenprotektion in Anlehnung an das Verfahren zur Myokardprotektion nach Bretschneider im Vergleich zum Euro-CollinsVerfahren. Z. Transplantationsrned. Nr. 1 (1989), 15-32
Gubematis G. et al.:HTK-solution (Bretschneider) for human livertransplantation first clinical experiences. Langenbecks Arch. Chir. 375 (1990), 66-70
KEHRER, G. et al.: Postischemic Diagnostic Localization of Tubular Lesions. Kim. Wschr. 68 (1990), 223-226
KEHRER, G. et al. Glycogen effects on energy state and passive electric properties of liver during protection. Z. Gastroenterologie, 28 (1990), 147- 156
KEHRER, G. et al. Glucose Content and Efficiency of Glycolysis in Protected lschemic Kidneys of Different Species. J. of Investigative Surg. 3 (1990) 147-168
PICHLMAYR, R. et al. Technique and preliminary results of extracorporeal liver surgery (bench procedure) and of surgery on the in situ perfused liver. Br. J. Surg. 77 (1990), 21-26
VIEWEG, J. et al.: Postischämische Normalfunktion von VerwandtennierenTranspiantaten nach Protektion mit HTK-Losung. Urologe A, 30 (1991), 256-259
KALLERHOFF, M. et al: A new method for conservative renal surgery - experimental and first clinical results. Langenbecks Arch. Chir. 375 (1990), 340-346
KEHRER, G. et al.: Heptanol effects on protected livers. Z. Gastroenterol. 28 (1990), 665-672
LAMESCH, P. et al.: In-situ Protection der Leber mit der HTK-Losung nach Bretschneider. Langenbecks Arch. Chir. 376 (1991), i.Druck
KEHRER, G. et al.: Influence of tissue acidification and halothane anesthesia on hepatic electrical and biochemical properties during ischemia. Z. Gastroenterol. 29 (1991), 22-30
MARZI, I. et al.: Microcirculatory disturbances and leucocyte adherence in transplanted livers after cold storage in Eurocollins, UW and HTK solutions. Transplant lnt. 4 (1991), 45-50
Ackemann, J. et al.: Celsior Versus Custodiol: Early Postisehemic Recovery After Cardioplegia and Ischemia at 5°C. The Annals of Thoracic Surgery 74 (2002), 522-9
Careaga,G.et al.: Clinical Impact of Histidine-Ketoglutaric-Tryptophan (HTK) Cardioplegic Solution on the Perioperative Period in Open Heart Surgery Patients. Arch. of Medical Research 32 (2001), 296-299
Vega et al.:A multicenter randomized, controlled trial of Celsior for flush and hypothermic storage of cardiac allografts. Ann Thorac Surg, 71 (2001):1442-1447
Wieselthaler et al.: Improved graft function using a new myocardial preservation solution: Celsior. Preliminary data from a randomized prospective study. Transplant Proc, 31 (1999), 2067-2070
SCHNABEL, Ph.A. et al.: Limitierungen einer Beurteilung subendokardialer Strukturprotektion anhand von Nadelbiopsien. Z. Herz-, Thorax-, GefäBchir. 5 (1991), 53-67
SCHNABEL, Ph.A.: The ultrastructural effects of global ischemia on Purkinje fibres compared with working myocardium: a quantitative and morphometric investigation on the canine heart. Virchows Archiv A. Pathol. Anat. 418 (1991), 17-25
ZERKOWSKI, H.-R. et al: Konzept zur Lungen- und Herz-Lungen-Präservation im Rahmen der Multiorganentnahme. Langenbecks Arch. f. Chir. 376 (1991), 3-8
GEBHARD, M.M. et al. Myocardial Protection and lschemia Tolerance of the Globally Ischemic Heart. Thorac. cardiovasc. Surg. 38 (1990), 55-59
SCHMIEDL, A. et al.: Influence of Pretreatment on Interstitial and Intracellular Space of Canine Left-Ventricular Myocardium. Ada Anat. 138 (1990), 175-1 81
SCHMIEDL, A. et al.: The surface to volume ratio of mitochondria, a suitable parameter for evaluating mitochondrial swelling. Virchows Arch. A. Pathol. Anat. 416 (1990), 305-315
SCHNABEL, Ph.A. et al.: Occurrence and prevention of contraction bands in Purkinje fibres, transitional cells and working myocardium during global ischemia. Virchows Arch. A. Pathol. Anat. 417 (1990), 463-471
SCHNABEL, Ph.A. et al.:Ultrastructural effects induced by global ischemia on the AV mode compared with the working myocardium. Virchows Arch. A. Pathol. Anat. 416 (1990), 317-328
SINGER, D. et al.: Metabolic Reduction in Hypothermia: Pathophysiological Problems and NaturalExamples (Part 1 + 2). Thoracic Cardiovasc. Surg. 38 (1990), 205-219
PANZNER, R. et al.: Reperfusion Arrhythmias After Cardioplegia Using Bretschneider-HTK Solution. Thoracic Cardiovasc. Surg. 38 (1990), 370
REICHART B.; H. REICHENSPURNER: Herztransplantation - aktueller Stand und Entwicklung. Internist 31(1990), 641-647
WOLLERT, H.-G. et al. Perioperative assessment of cardiac energy metabolism by means of arterio-coronary venous difference in lactate concentration (acDL). Eur. J. Cardio-thorac Surg 4 (1990), 278-283
WILSON, G.J. et al. European Versus North American Cardioplegia. Thorac. and Cardiovasc. Surgeon 38 (1990), 10-14
GEBHARD, M.M. et al.: Cardioplegia Principles and Problems. In: Physiology and Pathophysiology of the Heart 2nd Ed. N. Sperelakis, KluwerAcad. Publishers, 1989, p. 655-669
KROHN, E. et al.:The cardioplegic solution HTK: effects on membrane potential, intracellular K+ and Na+ activities in sheep cardiac Purkinje fibres. Pflugers Arch. 415 (1989), 269-275
MINTEN, J. et al.Optimal storage temperature and benefit of hypothermic cardioplegic arrest for long-term preservation of donor hearts: a study in the dog. Transplant tnt. 1(1988). 19-25
GEBHARD, M.M. et al. Impendance Spectroscopy: a Methode for Surveillance of the Heart. Thorac. cardiovasc. Surg. 35 (1987), 26-32
GEBHARD, M.M. et al.: Bretschneider’s Histidine Buffered Cardioplegic Solution: Concept; Application and Efficiency. In: Myocardial Protection in Cardiac Surgery. (ed). A.J. Roberts, Marcel Dekker Inc., New York - Basel, 1987, p. 95-119
HEINEMEYER D. et al. Intracellular pH Measurement during Cardiac Arrest in Ventricular Myocardium by Bretschneider’s Cardioplegic Solution HTK and St. Thomas-Hospital Solution with and without Procaine. Thorac. cardiovasc. Surg. 35 (1987), 48-52
PREUSSE, C.J. et al. High Volume Cardioplegia. Annales Chirugiae et Gynaecologiae 76 (1987), 39-45
SCHNABEL, Ph. A. et al.Myocardial Protection: Left Ventricular Ultrastructure after Different Forms of Cardiac Arrest. Thorac. carciiovasc. Surg. 35 (1987), 148-156
PREUSSE, C.J. et al. Myocardial Equilibration Procedures with High Volume Cardioplegia. Thai. J. Surg. 6 (1986), Nr.4
PREUSSE, C. J. et al. Energy demand of cardioplegically perfused human hearts. J. of cardiovasc. Surg. 26 (1985), 558-563
BRETSCHN EIDER, H.-J. et al. Cardioplegia - Principles and Problems. Physiol. and Pathophysiology ‘of the heart. M. Nijhoff Public. Boston, 1984 p. 605-616
GEGHARD, M.M. et al. Different Effects of Carclioplegic Solution HTK during Single or Intermittant Administration. Thorac. cardiovasc. Surg. 32 (1984), 271-276
PREUSSE, C.J. at al. Postischemic myocardial function after preischemic application of Propanolol or Verapamil. J. of Cardiovasc. Surg. 25 (1984), 158-164
SCHULTE, H. D. et at. Coronary Venous Blood Parameters During Postischemc Reperfusion After Mitral Valve Replacement. Mohl et at. (Ed.), The Coronary Sinus, Steinkopif, Darmstadt, 1984, 297- 304
GEBHARD, M.M. et al. Calcium-free Cardioplegia - pro*. Eur. Heart J. 4(1983), 151-160
STAPENHORST K. Prolonged Safe Tschemic Cardiac Arrest Using Hypothermic Bretschneider Cardioplegia Combined with Topical Cardiac Cooling. Thorac. cardiovasc. Surg. 29 (1981), 272-274
BRETSCHNEIDER, H.-J. Myocardial Protection. Thorac. cardiovasc. Surg. 28 (1980), 295-302.
GORLACH, G. et al.: Factors Determining Ventricular Fibrillation after Induced Cardiac Arrest. Thorac. cardiovasc. Surg. 39 (1991), 140-142
PREUSSE, C.J. et al.: Postischemic Metabolism of Infant Hearts Following Either lschemic or Cardioplegic Arrest. In: Perspectives in Pediatric Cardiology, Volume 2; ed. G. Crupi et al
SCHELD, H.H. et al.: Technik der koronaren Endarteriektomie. Z. Herz-, Thorax-, Gefäfchir. 1 (1987), 91-96
COURAUD, L. et al.: Lung and heart-lung transplantation for end-stage lung disease. Cardiothoracic Surg. 4 (1990)
SCHELD, H.H. et al.: Resection of a Heart Tumor using Autotransplantation. Thorac. cardiovasc. Surg. 36 (1988), 40-43
BOLDT, J. et al.: l Hyperosmolarer Volumenersatz in der Herzchirurgie. Anaesthesist 39 (1990).
POSIVAL, H. et al.: Extended donor criteria in cardiac transplantation. Poster
GALLANDAT, R.C.G. et al.: Clinical Effect of Bretschneider HTK and St. Thomas cardioplegia on hemodynamic performance after Bypass measured. Thorac. Cardiovasc. Surg. 36 (1988), 151-156
OPPELL, U. von, et al.:Endothelial Cell Toxicity of Solid-Organ Preservation Solutions. Ann. Thorac. Surg. 50 (1990), 902-910
SCHUMANN, U. et al: Rhythmusstorungen in der frOhen postoperativeri Phase nach Herzklappenersatz. Z. Herz-, Thorax-, Gefälchir. 2 (1988), 13-17
REICHART, B. et al.: Heart and Heart-Lung-Transplantation: - Organ Preservation. R.S. Schulz-Verlag 1990
GOERLACH, C. et al.: Perioperative myocardial injury in patients undergoing aortic valve replacement. J. Cardiovasc. Surg. 31(1990), 505-508
PREUSSE, C.-J. et al.: Einleitung des kUnstlichen Herzstillstandes in der Erwachsenen- und Kinderherz Chirurgie. Extrakorporale Zirkulation haute, Steinkopif-Verlag, 1991, S. 71-80
MOOSDORF, et al.: lntraoperative Koronarangioplastie. Zeitschr. f. Herz-, Thorax- und GefBchirurgie 3 (1989), 21-24
PILEGAARD, H.K. et al.: Early and late prognosis after valve replacement in aortic regurgitation. Preoperatiye risk stratefication and reasons for a more aggressive surgical approach. Thoracic and Cardiovascular Surg. 37 (1989), 231-237
WELZ, A. et al.: Zytotoxische Effekte verschiedener PerfusionslOsungen auf das Endothel venOser und arterietlerTransplantate. Thoracic and Cardiovascular Surg. 39 (1991), Suppl. 236-240
HAVEL, M.: Basic principles of cardioplegic management in donor heart preservation. Clinical Therapeutics 13 Nr. 2 (1991), 289-303
DOETSCH, N.: HTK-solution and L-tryptophan. Question and answers. Eurotranspiant Newsletter 76 (1990), 22-24
KRIAN, A. et al: The Arterial Switch-Operation: Early and Midterm (6 years) Results with Particular Reference to Technical Problems. Thorac. cardiovasc. Surg. 39 (1991), 160-165
KONERTZ, W. et al.: Pulmonalkiappenallograft in Aortenposition - FrOhergebnisse bei 30 konsekutiven Patienten. Z. Herz-, Thorax-, GefaIchirurgie 5 (1991), 68-74
GAMS, E. et al.: Significance of the Subvalvular Apparatus for Left-Ventricular Dimensions and Systolic Function: Experimental Replacement of the Mitral Valve. Thorac. cardiovasc. Surg. 39 (1991), 5-12
SCHNABEL; Ph.A. et al.: Patterns of Structural Deterioration Due to lschemia in Purkinje Fibres and Different Layers of the Working Myocardium. Thorac. cardiovasc. Surg. 39 (1991), 174-182
PREUSSE; C.J. et al.: Cardioplegia for Repeat Valve Surgery. From: A Textbook of Cardioplegia for Difficult Clinical Problems (Engelmann RM et al. (eds.)), Futura Publishing Company (1992), 203- 219
BRETSCHNEIDER, H.J.: OrganObergreifencie Prinzipieri zur Verlngerung der lschämietoleranzl Leopoldina (R.3) 37 (1992), 161-174
BRINKMANN, G. et al: Die Wirkung der Kardioplegielosungen nach Belzer und Bretschneider auf den myokardialen Eriergiestoffwechsel. Zeitschrift für Kardiologie 81(1992), 339-344
BRETSCHNEIDER, H.J. et al.: Significance of myocardial predamage and condition in ischemic tolerance of the heart. In: Cardiothoracic Surgery. K. Minami et al. (ed), Elsevier Science Publishers, 1992, p.35-44
MEISNER, H. et al.: The switch operation: indication and results. In: Cardiothoracic Surgery. K. Minami et al. (ed.), Elsevier Science PubNshers, 1992, p. 17-33
PREUSSE, C.J. et al.: Intraoperative Anwendung der Bretschneider Methode. Kardiotechnik Heft 1/1993
LOEBE, M. et al.: Herztransplantation - Indikation und Ergebnisse. Zentralblatt für Chirurgie, 117 (1992), 681-688
HENDRY, P.J. et al.: A comparison of intracellular solutions for donor heart preservation. Journal of Thoracic and Cardiovascular Surgery, 105 (1993), 667-673
PREUSSE, C.J.: Cardioplegia with an intracellular formulation. In: ischemia-reperfusion in cardiac surgery, PiperHM and Preusse CJ (ads.), KiuwerAcad. Publishers (1993), p. 107-134
DOETSCH, N.: Systemische Auswirkungen histidingepufferter kardioplegischer LOsung HTK nach Bretschneider. W. Pabst Verlag, 1990
HACHIDA, M. et al.: Improvement of postoperative management due to a new cardioplegia HTK solution. ICU & CCU 17(9) (1993), 895-899
SCHELD, H.H. et al: Koronarchirurgie - Münsteraner Konzept. Z. Herz-, Thorax-, Gefät3chir. 10 (1996); 53-60
GU, K. et al.: HTK Solution is more effective than UW Solution for Cardiac Preservation. Transpl. Proceedings 28 (1996), 1906-1907
HACHIDA, M. et al.:Effect of HTK solution for myocardial preservation. J. Cardiovasc. Surg. 37 (1996), 269- 274
HACHIDA, M. et al.: Clinical Assessment of Prolonged Myocardial Preservation for Patients with a severely dilated heart. Ann. Ttiorac. Surg. 64 (1997), 59-63
KOERNER, M.M. et al.: Cardiac transplant survival in relation to preservation. G.M. Collins, J.M. Dubernard, W. Land and G.G. Persijn (eds.). Procurement, Preservation and Allocation of Vascularized Organs 285-291, 1997 KiuwerAcad. Publishers
KU, K. et al.: Prolonged hypothermic cardiac storage with histidirie-tryptophan-ketoglutarate solution. Transplantation 64 (1998), 971-975
Holper, K. et al.: Technical refinements in myocardial protection: Infants — Adults. Thoracic. Cardiovasc. Surg. 46 (1998), 292-297
Schütt,U.et al.: Organ preservation in heart and heart-lung transplantation using HTK-Bretschneider Solution. VIII. ISCTS Kongress, Houston, 1998
Kober, I.M. et.al.: HTK vs. UW solution for myocardial protection during moderate hypothermia. Eur. Surg. Res. 29 (1997), 264-272
Sakata, J. et al.: Comparison of Clinical Outcome between Histidine-Tryptophan-Ketoglutarate Solution and Cold Blood Cardioplegic Solution in Mitral Valve Replacement. J. Card. Surg. 13 (1998), 43-47
|
|
||||
|
|
|
|
|
|
|
||||
|
|
||||
|
|
|
|
|
|